Characteristics and differences of db/db and KK-Ay Mouse as Diabetic Nephropathy Model
Affiliation:

Jiangsu Institute of Materia Medica

  • Article
  • | |
  • Metrics
  • |
  • Reference [19]
  • | | | |
  • Comments
    Abstract:

    Objective To investigate the characteristics and differences of db/db and KK-Ay mice as diabetic nephropathy (DN) model, and to verify them with Irbesartan treatment. Methods 102 db/db and 102 KK-Ay mice at 12 weeks of age were selected and grouped based on urine ACR (ratio of microalbuminuria MAU and CRE) and UCFP (24-hour total urine protein), then they were given Irbesartan (40mg?kg-1), experimental animal drinking water (model group), and other test articles, with 13 mice in each group. Wild type C57BL/6J (WT) was used as normal control group. Clinical observation was performed daily and mice were weighed every week, together with irregular monitoring of ACR and UCFP. At the end of administration, brain, liver, lung and kidneys were dissected and weighed, organ coefficients were calculated (organ weight ×1000/ animal body weight). Blood was collected and serum TP, Alb, BUN, GLU, TG and CHO were detected. The histopathological changes of renal tissue were observed by HE, MASSON and PAS staining. Results A total of 5 KK-Ay died in 8 weeks and 21 db/db died in 6 weeks;ACR increased with age in db/db and KK-Ay groups, but decreased in Irbesartan groups without statistical difference (p>0.05); UCFP increased with age in KK-Ay group and decreased significantly after Irbesartan treatment (p?0.05); Compared with WT, renal coefficients of db/db and KK-Ay mice had no significant changes (p>0.05), liver coefficients increased significantly (p?0.01), head coefficients decreased significantly (p?0.01), but they did not change after Irbesartan treatment (p>0.05); Compared with WT, serum GLU and TG of db/db and KK-Ay mice were significantly increased (p?0.01), but only that of KK-Ay mice were significantly decreased after Irbesartan treatment (p?0.01); Both db/db and KK-Ay kidneys showed an increase in mesangial matrix and mesangial cells proliferation, and the lesion degree was reduced in the Irbesartan treatment groups. Conclusion Both db/db and KK-Ay at 12 weeks of age can be used as DN models. Compared with db/db, KK-Ay mice have smaller individual differences in ACR and MAU, fewer animal deaths after urine collection, and significant improvements in GLU and TG after treatment, making it more suitable for studying the efficacy and mechanism of DN.

    Reference
    [1] Sitara Ghosh, Ankana Ghosh, Ashitha Rajanan, et al. Natural coumarins: Preclinical evidence-based potential candidates to alleviate diabetic nephropathy[J]. Phytomedicine Plus, 2022, 2(4):100379-100394. https://doi.org/10.1016/j.phyplu.2022.100379.
    [2] Xiaoyu Zhu, Xingli Xu, Chigang Du, et al. An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy[J]. Biomedicine & Pharmacotherapy, 2022, 153(9) : 113438-113456. https://doi.org/10.1016/j.biopha.2022.113438.
    [3] 徐卓, 项想, 尚尔鑫, 等. 丹参茎叶总酚酸对2型糖尿病肾病小鼠肠道菌群和短链脂肪酸的调节作用[J]. 药学学报, 2021, 56(4): 1035-1048.
    [4] 孙富华, 古丽革乃?巴斯提。中西医结合治疗糖尿病肾病进展[J]. 新疆中医药, 2020, 38(4): 111-114.
    [5] Christine P., Matthias K., Subramaniam P., et al. Present and future directions in diabetic kidney disease[J]. Journal of Diabetes and its Complications,2022,36(12):108357-108371. https://doi.org/10.1016/j.jdiacomp.2022.108357.
    [6] Frederikke E. Sembach, Mette V. ?stergaard, Niels Vrang, et al. Rodent models of diabetic kidney disease: human translatability and preclinical validity[J]. Drug Discovery Today 2021, 2020, 26(1):200-217. https://doi.org/10.1016/j.drudis.2020.05.004. [7] Nagasaka, S., Shimizu, A. Experimental Animal Models of Diabetic Kidney Disease[J]. Diabetic Kidney Disease, 2020,22(12):173-190. https://doi.org/10.1007/978-981-15-9301-7_13.
    [7] [8] Tesch GH, Lim AK. Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy[J]. Am J Physiol Renal Physiol, 2011,300(2):301-310.
    [8] [9] 郑敬民, 刘志红, 张鑫, 等. db/db小鼠糖尿病肾病相关基因的分析和克隆[J]. 生物化学与生物物理进展, 2003,30(3):406-411.
    [9] [10] 董哲毅, 华参, 高翔, 等. 2型糖尿病动物模型KK-Ay小鼠糖尿病肾病的鉴定[J]. 山东医药, 2008,48(13):17-19.
    [10] [11] 王蕾, 吴旭颖, 高玉龙, 等.KK鼠料快速建模对KK/Upj-A~y/J小鼠相关指标的影响[J]. 中国比较医学杂志,2019,29( 9) : 42-48.
    [11] [12] Azushima, K., Gurley, S., Coffman, T. Modelling diabetic nephropathy in mice[J].Nat Rev Nephrol,2017, 24(10): 48-56. https://doi.org/10.1038/nrneph.2017.142.
    [12] [13] Betz, B., Conway, B.R. An Update on the Use of Animal Models in Diabetic Nephropathy Research[J]. Curr Diab Rep,2016,16(18):1-9. https://doi.org/10.1007/s11892-015-0706-2.
    [13] [14] Talukdar, A., Basumatary, M. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy[J]. Mol Biol Rep,2023,50(9):7759-7782. https://doi.org/10.1007/s11033-023-08621-z.
    [14] [15] Roohi, T.F., Mehdi, S., Aarfi, S. et al. Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin[J]. Diabetol Int ,2024,15(2): 145-169. https://doi.org/10.1007/s13340-023-00680-8.
    [15] [16] 国家药品监督管理局药审中心.慢性肾脏病治疗药物临床试验技术指导原则(公开征求意见稿[EB/OL]. (2022-11-16)[2024-06-04].
    [16] [17] Hu, S., Hang, X., Wei, Y. et al. Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review[J]. Cell Commun Signal,2024, 22(136):1-28. https://doi.org/10.1186/s12964-024-01502-3.
    [17] [18] Peng, W., Zhou, X., Xu, T. et al. BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease[J]. Cell Death,2022,13(254):1-12. https://doi.org/10.1038/s41419-022-04529-x.
    [18] [19] Huang, R., Fu, P. & Ma, L. Kidney fibrosis: from mechanisms to therapeutic medicines[J]. Sig Transduct Target Ther, 2023,8(129):1-20. https://doi.org/10.1038/s41392-023-01379-7.
    [19] [20] Thomas, H.Y., Ford Versypt, A.N. Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation[J]. J Biol Eng ,2022,16(19):1-13 https://doi.org/10.1186/s13036-022-00299-4
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:56
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:August 10,2024
  • Revised:November 18,2024
  • Adopted:May 06,2025
Article QR Code